TriMas Corporation reported strong first-quarter 2026 results, surpassing EPS and revenue forecasts with $0.24 EPS and $168.28 million in revenue. The company's stock rose 3.05% in pre-market trading, driven by organic growth, operational improvements, and strategic divestitures. TriMas also reaffirmed its full-year 2026 guidance, expecting continued sales growth and significant operating margin expansion.
Zacks Research downgraded TriMas (NASDAQ:TRS) from a "hold" to a "strong sell" rating. This follows a mixed performance from other analysts, with a consensus "Hold" rating and an average target price of $41.50. TriMas recently missed quarterly earnings estimates, reporting $0.40 EPS against $0.41 expected, and revenue of $155.49 million, below analyst estimates of $192.96 million.
Zacks Research has downgraded TriMas (NASDAQ:TRS) from a "strong-buy" to a "hold" rating, reflecting mixed analyst opinions with a consensus of "Moderate Buy" and an average price target of $41.50. Despite the downgrade, TriMas recently surpassed quarterly earnings and revenue estimates and provided positive FY2025 guidance. Insider activity shows a director purchasing 2,000 shares, and institutional ownership remains very high at 99.42%.
